A Leaner AngioDynamics Is A High-Risk Execution-Driven Story [Seeking Alpha]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Seeking Alpha
The recent approval of the AlphaVac F18 mechanical thrombectomy system for pulmonary embolism presents a significant opportunity in a large ($2B+) and growing market. The company's historical execution challenges raise concerns, but there is potential for a stronger, more profitable AngioDynamics if products like Auryon, AlphaVac, and NanoKnife are successful. Progress toward double-digit adjusted EBITDA margins in four or five years can support a fair value of $10 today, but this is a highly speculative call. I can't say that I have a lot of regrets about expressing my concerns in October 2023 that AngioDynamics, Inc. NASDAQ: ANGO ) is an execution-challenged med-tech story with a real value-trap risk. With the shares basically flat since Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- Insider Spends US$67k Buying More Shares In AngioDynamics [Yahoo! Finance]Yahoo! Finance
- AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment [Yahoo! Finance]Yahoo! Finance
- AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates [Yahoo! Finance]Yahoo! Finance
- AngioDynamics upgraded at Oppenheimer on pipeline progress [Seeking Alpha]Seeking Alpha
ANGO
Earnings
- 4/4/24 - Miss
ANGO
Sec Filings
- 4/9/24 - Form 10-Q
- 4/8/24 - Form 4
- 4/4/24 - Form 8-K
- ANGO's page on the SEC website